Literature DB >> 19302415

The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients.

Y Long1, E Chen, C Liu, F Huang, T Zhou, F He, L Liu, F Liu, H Tang.   

Abstract

Hepatocyte nuclear factors 4 alpha (HNF4alpha) and 3 beta (HNF3beta) are members of a group of liver-enriched transcription factors (LETFs) that play important roles in regulating the replication of hepatitis B virus (HBV). Using cell culture and animal models, we showed that HNF4alpha supports HBV replication in nonhepatic cells and HNF3beta inhibits HBV replication. However, the expression of HNF4alpha and HNF3beta in the liver tissue of chronic HBV-infected patients and the relationship between the levels of HNF4alpha and HNF3beta and HBV replication are unclear. In this study, liver biopsy specimens from 86 chronic HBV-infected patients were collected. The expression levels of HNF4alpha, HNF3beta, hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) were detected by an immunohistochemical technique and the level of HBV DNA was checked by in situ hybridization with serial sections from liver biopsy tissue samples. We show here that samples with higher levels of HNF4alpha expression also have higher levels of HBsAg, HBcAg and HBV DNA. In contrast, in samples with higher levels of HNF3beta expression, levels of HBsAg, HBcAg and HBV DNA were lower. There was a positive correlation between HNF4alpha expression and HBV replication, and a negative correlation between HNF3beta expression and HBV replication, in the liver of chronic HBV-infected patients. This suggests that HNF4alpha and HNF3beta likely participate in HBV replication in patients with HBV infection, or that HBV replication may somehow influence the expression of HNF4alpha and HNF3beta in the liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302415     DOI: 10.1111/j.1365-2893.2009.01089.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  13 in total

Review 1.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Authors:  Bidisha Mitra; Roshan J Thapa; Haitao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2018-08-24       Impact factor: 5.970

2.  Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha.

Authors:  Jun Xu; Weizhen Gu; Chaoyan Li; Xiao Li; Guozhen Xing; Yan Li; Yanhui Song; Wenming Zheng
Journal:  J Nat Med       Date:  2016-03-11       Impact factor: 2.343

Review 3.  Roles of hepatocyte nuclear factors in hepatitis B virus infection.

Authors:  Doo Hyun Kim; Hong Seok Kang; Kyun-Hwan Kim
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

4.  Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.

Authors:  Zhenhuan Zhao; Wei Hong; Zhengyang Zeng; Yingliang Wu; Kanghong Hu; Xiaohui Tian; Wenxin Li; Zhijian Cao
Journal:  J Biol Chem       Date:  2012-07-12       Impact factor: 5.157

5.  Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection.

Authors:  En-Qiang Chen; Hui Sun; Ping Feng; Dao-Yin Gong; Cong Liu; Lang Bai; Wen-Bing Yang; Xue-Zhong Lei; Li-Yu Chen; Fei-Jun Huang; Hong Tang
Journal:  Virol J       Date:  2012-01-18       Impact factor: 4.099

6.  Impact of Nucleotide Mutations at the HNF3- and HNF4-Binding Sites in Enhancer 1 on Viral Replication in Patients with Chronic Hepatitis B Virus Infection.

Authors:  Eun-Young Cho; Hyung-Jin Kim; Channy Park; Hong-Seob So; Rae Kil Park; Haak Cheoul Kim
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

7.  Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma.

Authors:  Somenath Datta; Alip Ghosh; Debanjali Dasgupta; Amit Ghosh; Shrabasti Roychoudhury; Gaurav Roy; Soumyojit Das; Kausik Das; Subash Gupta; Keya Basu; Analabha Basu; Simanti Datta; Abhijit Chowdhury; Soma Banerjee
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

8.  HBx inhibits CYP2E1 gene expression via downregulating HNF4α in human hepatoma cells.

Authors:  Hongming Liu; Guiyu Lou; Chongyi Li; Xiaodong Wang; Arthur I Cederbaum; Lixia Gan; Bin Xie
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

9.  IL-23 enhances the malignant properties of hepatoma cells by attenuation of HNF4α.

Authors:  Qing Jiang; Yuanli Sun; Zilong Guo; Ru Chen; Simin Ma; Mingpeng Fu; Huifen Zhu; Qin Ning; Ping Lei; Guanxin Shen
Journal:  Oncotarget       Date:  2018-06-19

10.  Steroid receptor coactivator 3 inhibits hepatitis B virus gene expression through activating Akt signaling to prevent HNF4α nuclear translocation.

Authors:  Ming Li; Yi Wang; Xiaochun Xia; Pingli Mo; Jianming Xu; Chundong Yu; Wengang Li
Journal:  Cell Biosci       Date:  2019-08-13       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.